Trial Profile
Phase II study of the response rate of induction chemotherapy with gemcitabine and carboplatin for operable non-small cell lung cancer before surgery
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 27 Feb 2017
Price :
$35
*
At a glance
- Drugs Carboplatin (Primary) ; Gemcitabine (Primary)
- Indications Non-small cell lung cancer
- Focus Biomarker; Therapeutic Use
- 13 Dec 2007 New trial record.